Altana Acquires 8.3 Percent Stake in GPC Biotech | GenomeWeb

NEW YORK, Nov. 1 – German pharmaceutical company Altana has agreed to make an equity investment of 34.2 million euros ($31.1 million) in GPC Biotech, GPC said Thursday.

GPC of Munich said it would issue 1.69 million of its shares to Altana at 20.25 euros a share. Following the transaction, Altana will hold an 8.3 percent stake in GPC, making it the second largest shareholder in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.